• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down0.23% Nasdaq Up0.45%

    Abbott Laboratories (ABT)

    -NYSE
    46.83 Up 0.20(0.42%) 10:58AM EDT - NYSE Real Time Price
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2014Dec 31, 2013Dec 31, 2012
    Total Revenue 20,247,000   19,657,000   19,050,000  
    Cost of Revenue9,218,000  9,193,000  8,899,000  
    Gross Profit 11,029,000   10,464,000   10,151,000  
    Operating Expenses
    Research Development1,345,000  1,371,000  1,461,000  
    Selling General and Administrative6,530,000  6,372,000  6,735,000  
    Non Recurring -   -   -  
    Others555,000  588,000  595,000  
    Total Operating Expenses -   -   -  
    Operating Income or Loss 2,599,000   2,133,000   1,360,000  
    Income from Continuing Operations
    Total Other Income/Expenses Net69,000  53,000  (1,260,000)
    Earnings Before Interest And Taxes2,668,000  2,186,000  100,000  
    Interest Expense150,000  145,000  320,000  
    Income Before Tax2,518,000  2,041,000  (220,000)
    Income Tax Expense797,000  53,000  (457,000)
    Minority Interest -   -   -  
    Net Income From Continuing Ops1,721,000  1,988,000  237,000  
    Non-recurring Events
    Discontinued Operations563,000  588,000  5,726,000  
    Extraordinary Items -   -   -  
    Effect Of Accounting Changes -   -   -  
    Other Items -   -   -  
    Net Income 2,284,000   2,576,000   5,963,000  
    Preferred Stock And Other Adjustments -   -   -  
    Net Income Applicable To Common Shares 2,284,000   2,576,000   5,963,000  

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.